Advantages of gross total resection in patients with astrocytoma: A population‑based study
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
A) Kaplan-Meier plots of 10-year survival by time period for patients... | Download Scientific Diagram
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas - Modern Pathology
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
.jpg "Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery")
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text
Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... | Download Scientific Diagram
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy | Journal of Cancer Research and Clinical Oncology
Survival patterns of oligoastrocytoma patients: A surveillance, epidemiology and end results (SEER) based analysis - ScienceDirect
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
Astrocytoma Treatment & Management: Approach Considerations, Surgical Care, Medical Care
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal
Current therapeutic approaches to diffuse grade II and III gliomas - Alberto Picca, Giulia Berzero, Marc Sanson, 2018
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
